IRIS
AUDRITO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.627
AS - Asia 1.808
NA - Nord America 1.315
SA - Sud America 224
AF - Africa 61
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.040
Salva come PNG Salva come JPEG
Nazione #
NL - Olanda 3.757
US - Stati Uniti d'America 1.246
RU - Federazione Russa 803
SG - Singapore 675
IT - Italia 395
CN - Cina 339
HK - Hong Kong 320
VN - Vietnam 210
BR - Brasile 176
DE - Germania 143
IE - Irlanda 111
FR - Francia 109
GB - Regno Unito 90
ID - Indonesia 56
SE - Svezia 41
IN - India 36
CA - Canada 32
ES - Italia 31
MX - Messico 29
BJ - Benin 27
FI - Finlandia 27
UA - Ucraina 27
KR - Corea 25
BD - Bangladesh 21
PL - Polonia 21
IQ - Iraq 17
CZ - Repubblica Ceca 16
AR - Argentina 15
AT - Austria 15
JP - Giappone 15
TR - Turchia 14
ZA - Sudafrica 14
PK - Pakistan 12
JO - Giordania 11
CH - Svizzera 10
LT - Lituania 8
VE - Venezuela 8
EC - Ecuador 7
BE - Belgio 5
DZ - Algeria 5
IL - Israele 5
MY - Malesia 5
RO - Romania 5
TH - Thailandia 5
TW - Taiwan 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
CO - Colombia 4
GR - Grecia 4
IR - Iran 4
MA - Marocco 4
PH - Filippine 4
UZ - Uzbekistan 4
BG - Bulgaria 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
MU - Mauritius 1
MZ - Mozambico 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 9.040
Salva come PNG Salva come JPEG
Città #
Amsterdam 3.745
Hong Kong 319
Singapore 290
San Jose 186
Ashburn 154
Beijing 118
Dublin 111
Lauterbourg 74
Los Angeles 67
Moscow 66
Turin 62
Council Bluffs 58
Milan 58
New York 56
Hanoi 55
Ho Chi Minh City 51
Jakarta 44
Munich 41
Vercelli 34
Novara 33
Jacksonville 30
São Paulo 28
Cotonou 27
Frankfurt am Main 27
Boardman 26
Buffalo 24
Orem 24
Warsaw 21
London 20
Manchester 20
Seoul 18
Chennai 17
Falkenstein 17
Santa Clara 17
Brno 16
Chandler 16
Chicago 16
Nuremberg 16
Mexico City 15
Atlanta 14
Brooklyn 14
Tokyo 14
Dearborn 13
St Louis 13
Stockholm 13
Genoa 12
Helsinki 12
Poplar 12
Rome 12
Amman 11
Dallas 11
Denver 11
Phoenix 11
Montreal 10
Ankara 9
Houston 9
Da Nang 8
Rio de Janeiro 8
San Francisco 8
Toronto 8
Vienna 8
Baghdad 7
Biên Hòa 7
Boston 7
Haiphong 7
Johannesburg 7
Bologna 6
Borgomanero 6
Brasília 6
Guangzhou 6
Lawrence 6
Princeton 6
Tianjin 6
Wilmington 6
Alessandria 5
Belo Horizonte 5
Bexley 5
Guarulhos 5
Hillsboro 5
Mumbai 5
Petaling Jaya 5
Querétaro 5
San Mateo 5
Shanghai 5
Valencia 5
Zurich 5
Can Tho 4
City of London 4
Como 4
Dhaka 4
Guayaquil 4
Hangzhou 4
Hải Dương 4
Las Vegas 4
New Delhi 4
Phủ Lý 4
Rawalpindi 4
Redondo Beach 4
San Lazzaro di Savena 4
Turku 4
Totale 6.457
Salva come PNG Salva come JPEG
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.963
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.954
Bi-directional crosstalk between NAD/NAMPT and IFN-γ/PD-L1axes in melanoma 161
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 136
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 130
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 127
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 121
NAMPT in drug-resistant melanoma: linking NAMPT-dependent metabolic reprogramming and immune regulation 115
NAMPT inhibition impairs mTOR-dependent regulation of translation in melanomaNAMPT inhibition impairs mTOR-dependent regulation of translation in melanoma. 107
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma 106
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets 100
P13-17: Effect of Ether Perfluoro Carboxyl Acid (PFAS) on Innate Immunity in Earthworms 100
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 98
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 96
The Extracellular NADome Modulates Immune Responses 93
Investigating the presence of eNAMPT/visfatin in human skimmed milk and milk fat globule membrane before and after Holder pasteurization. 91
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 89
NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment 83
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 79
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 77
Procedimento immunologico e kit per la diagnosi in vitro di patologie tumorali e/o infiammatorie 76
Impact of Holder pasteurization on protein and eNAMPT/Visfatin content in human breast milk 76
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 75
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 75
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 74
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 74
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 73
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 70
Immunological method and kit for in vitro diagnosis of tumor and/or inflammatory diseases 70
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 69
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 69
Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network 68
The hidden life of NAD+-consuming ectoenzymes in the endocrine system 68
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 65
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 65
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 62
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 61
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 61
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties 60
NAMPT AND AUTOANTIBODIES: A POSSIBLE ASSOCIATION FOR AUTOIMMUNE DIAGNOSTICS? 59
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle 57
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 57
DIFFERENT AQUAPORIN-4 EXPRESSION IN GLIOBLASTOMA MULTIFORME PATIENTS WITH AND WITHOUT SEIZURES 56
Loss of the heme exporter FLVCR1a impairs mitochondrial functionality: a new approach against colorectal cancer 55
NAMPT: A critical driver and therapeutic target for cancer 53
TBC1 domain-containing proteins are frequently involved in triple-negative breast cancers in connection with the induction of a glycolytic phenotype 52
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 51
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 49
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 49
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed and abundantly released from malignant pleural mesothelioma cells becoming a potential biomarker. 48
Effects of Ether Perfluoro Carboxyl Acids (PFECAs) on Innate Immunity in Earthworms (Eisenia fetida) 48
Targeting mitochondria by ss-31 ameliorates the whole body energy status in cancer-and chemotherapy-induced cachexia 48
CD38 in chronic lymphocytic leukemia: from bench to bedside? 48
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 46
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 45
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 45
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 44
BI-DIRECTIONAL CROSSTALK BETWEEN NAD/NAMPT AND IFN-Γ/PD-L1 AXES IN MELANOMA 44
Translational reprogramming in BRAF inhibitors resistant melanoma: the impact of NAMPT/NAD metabolism in mTOR-dependent regulation of protein synthesis. 44
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 44
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 44
Molecular insights into the interaction between human nicotinamide phosphoribosyltransferase and Toll-like receptor 4 44
Special Issue: "Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets" 43
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 43
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 40
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 39
The dual face of NAMPT: Intracellular/extracellular protein and diagnostic/therapeutic target in cancer 39
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 39
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 39
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia 38
Editorial: Metabolic reprogramming in cancer 37
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 37
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 37
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications 37
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 36
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 35
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics 35
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options 34
Pancreatic cancer immune evasion mechanisms: the immunosuppressive role of P2RX1-negative neutrophils 33
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model 32
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 31
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting 31
Regulation Of CLL Growth and Trafficking By The Enzymatic Functions Of CD38: Implications For Therapeutic Targeting 30
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 26
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 24
Editorial: Tumor-host interactions: metabolic and signaling pathways altered in cancer, immune and stromal cells 23
null 23
PRO-INFLAMMATORY ROLE OF EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE IN CYSTIC FIBROSIS 22
Totale 9.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 5 0
2021/202228 0 0 4 1 1 0 2 2 1 5 4 8
2022/2023197 6 5 7 2 3 17 3 12 119 6 9 8
2023/2024389 13 26 32 18 62 4 86 33 6 5 22 82
2024/20251.346 46 5 119 34 92 54 177 91 456 53 56 163
2025/20267.076 167 153 171 403 416 340 508 597 4.035 286 0 0
Totale 9.150